These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1490658)
81. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH. Jeppsson S; Nilsson KO; Rannevik G; Wide L Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858 [TBL] [Abstract][Full Text] [Related]
82. Factors influencing effectiveness of thyrotropin-releasing hormone therapy for severe epilepsy in childhood: significance of serum prolactin levels. Matsumoto A; Kumagai T; Takeuchi T; Miyazaki S; Watanabe K Epilepsia; 1989; 30(1):45-9. PubMed ID: 2492223 [TBL] [Abstract][Full Text] [Related]
83. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly. Watanobe H; Tamura T; Sasaki S; Takebe K Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416 [TBL] [Abstract][Full Text] [Related]
84. Influence of prostaglandins and thyrotropin releasing hormone (TRH) on hormone secretion and growth in wether lambs. Davis SL; Anfinson MS; Klindt J; Ohlson DL Prostaglandins; 1977 Jun; 13(6):1209-20. PubMed ID: 407628 [TBL] [Abstract][Full Text] [Related]
85. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects]. Shimizu T; Inoue K Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310 [TBL] [Abstract][Full Text] [Related]
86. Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome). Laron Z; Klinger B; Silbergeld A J Pediatr Endocrinol Metab; 1999; 12(2):145-52. PubMed ID: 10392360 [TBL] [Abstract][Full Text] [Related]
87. The effect of thyrotropin-releasing hormone (TRH) and somatostatin (GHRIH) on growth hormone and prolactin secretion in vitro and in vivo in the domestic fowl (Gallus domesticus). Harvey S; Scanes CG; Chadwick A; Bolton NJ Neuroendocrinology; 1978; 26(4):249-60. PubMed ID: 98725 [TBL] [Abstract][Full Text] [Related]
89. Effect of acute intravenous growth hormone-releasing factor on plasma prolactin in short children and patients with growth hormone deficiency. Chatelain PG; Sassolas G; Catbeh N; Bio-Laporte S; Ferry S; Claustrat B; David M; François R Horm Res; 1985; 22(1-2):46-51. PubMed ID: 3928476 [TBL] [Abstract][Full Text] [Related]
90. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286 [TBL] [Abstract][Full Text] [Related]
91. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas. Serri O; Somma M; Rasio E; Brazeau P Clin Endocrinol (Oxf); 1989 Jan; 30(1):65-75. PubMed ID: 2505955 [TBL] [Abstract][Full Text] [Related]
92. Endocrine control of Na+,K+-ATPase and chloride cell development in brown trout (Salmo trutta): interaction of insulin-like growth factor-I with prolactin and growth hormone. Seidelin M; Madsen SS J Endocrinol; 1999 Jul; 162(1):127-35. PubMed ID: 10396029 [TBL] [Abstract][Full Text] [Related]
93. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. Chatelain PG; Sanchez P; Saez JM Endocrinology; 1991 Apr; 128(4):1857-62. PubMed ID: 2004605 [TBL] [Abstract][Full Text] [Related]
94. Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Massoud AF; Hindmarsh PC; Brook CG Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393 [TBL] [Abstract][Full Text] [Related]
95. Effect of long-term administration of porcine growth hormone-releasing factor and(or) thyrotropin-releasing factor on growth hormone, prolactin and thyroxine concentrations in growing pigs. Dubreuil P; Couture Y; Pelletier G; Petitclerc D; Delorme L; Lapierre H; Gaudreau P; Morisset J; Brazeau P J Anim Sci; 1990 Jan; 68(1):95-107. PubMed ID: 2105928 [TBL] [Abstract][Full Text] [Related]
96. Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease. Panerai AE; Salerno F; Manneschi M; Cocchi D; Müller EE J Clin Endocrinol Metab; 1977 Jul; 45(1):134-40. PubMed ID: 406272 [TBL] [Abstract][Full Text] [Related]
97. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type). Walker JL; Van Wyk JJ; Underwood LE J Pediatr; 1992 Oct; 121(4):641-6. PubMed ID: 1403403 [TBL] [Abstract][Full Text] [Related]
98. Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group. Arosio M; Macchelli S; Rossi CM; Casati G; Biella O; Faglia G Eur J Endocrinol; 1995 Oct; 133(4):430-9. PubMed ID: 7581966 [TBL] [Abstract][Full Text] [Related]
99. Clinical profile of Laron dwarfism - experience from a tertiary care institute in Chennai. Sethuraman C; Venkatasamy S J Pediatr Endocrinol Metab; 2023 May; 36(5):466-469. PubMed ID: 36957988 [TBL] [Abstract][Full Text] [Related]
100. A case of Laron syndrome diagnosed in Slovenia. Krzisnik C; Silbergeld A; Laron Z J Pediatr Endocrinol; 1994; 7(4):365-9. PubMed ID: 7735377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]